Finanças

Discussões Sinais técnicos Previsão Sazonais

EBITDA de EVER SUPREME BIO TECHNOLOGY CO LTD.

Dados anuais

2017

2018

2019

2020

2021

2022

2023

TTM

‪‪−150,00 M‬‬

‪0,00‬

‪‪150,00 M‬‬

‪‪300,00 M‬‬

‪‪450,00 M‬‬

Período

Valor

Variação

Variação %

TTM

‪‪409,66 M‬‬

+‪‪39,62 M‬‬

+‪10,71‬%

2023

‪‪370,04 M‬‬

+‪‪50,70 M‬‬

+‪15,88‬%

2022

‪‪319,34 M‬‬

+‪‪167,32 M‬‬

+‪110,06‬%

2021

‪‪152,03 M‬‬

+‪‪277,20 M‬‬

—

2020

‪‪−125,18 M‬‬

‪‪−6,20 M‬‬

‪−5,21‬%

2019

‪‪−118,98 M‬‬

‪‪−32,06 M‬‬

‪−36,88‬%

2018

2017

Dados trimestrais

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪40,00 M‬‬

‪‪80,00 M‬‬

‪‪120,00 M‬‬

‪‪160,00 M‬‬

Período

Valor

Variação

Variação %

Q3 '24

‪‪102,18 M‬‬

+‪‪16,18 M‬‬

+‪18,81‬%

Q2 '24

‪‪86,00 M‬‬

+‪‪6,09 M‬‬

+‪7,62‬%

Q1 '24

‪‪79,91 M‬‬

‪‪−61,66 M‬‬

‪−43,56‬%

Q4 '23

‪‪141,57 M‬‬

+‪‪16,22 M‬‬

+‪12,94‬%

Q3 '23

‪‪125,35 M‬‬

+‪‪55,36 M‬‬

+‪79,09‬%

Q2 '23

‪‪69,99 M‬‬

+‪‪36,87 M‬‬

+‪111,33‬%

Q1 '23

‪‪33,12 M‬‬

‪‪−73,83 M‬‬

‪−69,03‬%

Q4 '22

‪‪106,95 M‬‬

+‪‪23,16 M‬‬

+‪27,63‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20